Rain Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RAIN and other ETFs, options, and stocks.

About RAIN

Rain Therapeutics, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. 

CEO
Avanish Vellanki
CEOAvanish Vellanki
Employees
44
Employees44
Headquarters
Newark, California
HeadquartersNewark, California
Founded
2017
Founded2017
Employees
44
Employees44

RAIN Key Statistics

Market cap
128.31M
Market cap128.31M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
45.37K
Average volume45.37K
High today
$5.50
High today$5.50
Low today
$4.03
Low today$4.03
Open price
$4.19
Open price$4.19
Volume
72.00K
Volume72.00K
52 Week high
$17.31
52 Week high$17.31
52 Week low
$2.15
52 Week low$2.15

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

RAIN Earnings

-$1.93
-$1.29
-$0.64
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, After Hours
ActualExpected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.